Effects of the opioid antagonist naloxone on release of luteinizing hormone in mares during the anovulatory season.
To investigate an involvement of endogenous opioids in the regulation of circannual changes in reproductive activity, effects of the opioid antagonist naloxone on the concentration of immunoreactive and bioactive luteinizing hormone (LH) in plasma were measured in mares during the anovulatory season. Naloxone (0.5 mg/kg i.v.) caused a significant increase (P < 0.05) in immunoreactive as well as bioactive LH concentration in plasma. The amplitude of the increase in LH concentrations measured with an in vitro bioassay was more pronounced than the amplitude of the increase in LH secretion determined by radioimmunoassay. This indicates that although in seasonal anovulatory mares the bioactivity of LH in plasma is low, highly bioactive LH is present in the anterior pituitary and can be released by naloxone. The LH response to naloxone did not depend on the degree of ovarian follicular activity. It can be concluded that a tonic opioid inhibition of LH release is present in mares during at least part of the anovulatory season and that endogenous opioids seem to be involved in the regulation of seasonal reproductive activity in the horse. In contrast to the situation during the breeding season, the opioid systems regulating LH release are activated independently of luteal progesterone.
Aurich
C
C
Institut für Reproduktionsmedizin, Tierärztliche Hochschule Hannover, Germany.
Schlote
S
S
Hoppen
H O
HO
Klug
E
E
Hoppe
H
H
Aurich
J E
JE
D000818:Animals; D000858:Anovulation / Q000503:physiopathology*; D001681:Biological Assay; D004958:Estradiol / Q000097:blood; D005260:Female; D006736:Horses / Q000502:physiology*; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism*; D009270:Naloxone / Q000494:pharmacology*; D006080:Ovarian Follicle / Q000187:drug effects; D010903:Pituitary Gland, Anterior / Q000187:drug effects*; D011374:Progesterone / Q000097:blood; D011863:Radioimmunoassay; D012621:Seasons
D009270:Naloxone; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone